INTRODUCTION: This study aimed to identify a follow-up modality that can be used to evaluate therapeutic responses in @entity1 receiving treatment for brucellar sacroillitis and to determine whether antibiotherapy can be stopped. METHODOLOGY: A total of 32 @entity1 with sacroiliac joint involvement demonstrated via magnetic resonance imaging or bone scintigraphy were followed up and treated. @entity1 received 200 mg/day of @entity3403 and 600-900 mg/day of @entity1215 for 3-21 months, and 1 g/day of @entity3639 for 21 days. RESULTS: The mean age of the 32 @entity1 involved was 21.81  4.09. In total, 10/32 @entity1 did not complete therapy, and the remaining 22 @entity1 received combination antibiotic treatment for a mean of 8.95  4.34 months. Of the 22 @entity1 , 15 underwent MRI, and 7 of them did not consent to MRI. Similarly, 17 @entity1 were followed up by bone scintigraphy, and 5 @entity1 did not have scintigraphy results. In 9/17 @entity1 followed up with bone scintigraphy, @entity6592 findings were found to reduce after a mean of 7.44  3.71 months, whereas in 12/15 @entity1 on whom MRI was performed,   there were no active @entity6592 findings for a mean of 6.95  2.83 months. CONCLUSIONS: While active involvement findings in bone scintigraphy were observed for a longer period in scintigraphy images, active @entity6592 findings disappeared in a relatively shorter period of time with MRI. Therefore, we have demonstrated that high-resolution MRI is a very sensitive technique compared to scintigraphy.

Can imaging modalities be used as follow-up criteria after XXXX treatment?

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity6592 :: ('MESH:D058566', 'Disease') :: ['sacroiliitis'] @entity3403 :: ('MESH:D004318', 'Chemical') :: ['doxycycline'] @entity3639 :: ('MESH:D013307', 'Chemical') :: ['streptomycin'] @entity1215 :: ('MESH:D012293', 'Chemical') :: ['rifampicin']
@entity6592 :: (MESH:D058566,Disease) :: ['brucellar sacroiliitis']
